InfuSystem Holdings, Inc (INFU) stock
INFUNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 15/304% below fair value
$14.72−0.07 (-0.47%)
Close on Nov 13, 2026Market cap $293.18MP/E 32.7Yield –
InfuSystem EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
InfuSystem's EPS for the twelve months ending Sep 30, 2026 was $0.45, up 73.1% year over year. For fiscal 2025 it was $0.31, up 181.8% from the year before. Over ten years it grew 10.0% a year on average. The highest annual figure on record is $0.80 in fiscal 2020.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $0.31 | +181.8% |
| FY2024 | Dec 31, 2024 | $0.11 | +175.0% |
| FY2023 | Dec 31, 2023 | $0.04 | – |
| FY2022 | Dec 31, 2022 | $0.00 | -100.0% |
| FY2021 | Dec 31, 2021 | $0.06 | -92.5% |
| FY2020 | Dec 31, 2020 | $0.80 | +1042.9% |
| FY2019 | Dec 31, 2019 | $0.07 | – |
| FY2018 | Dec 31, 2018 | -$0.05 | – |
| FY2017 | Dec 31, 2017 | -$0.91 | – |
| FY2016 | Dec 31, 2016 | -$0.01 | -108.3% |
| FY2015 | Dec 31, 2015 | $0.12 | -20.0% |
| FY2014 | Dec 31, 2014 | $0.15 | +87.5% |
| FY2013 | Dec 31, 2013 | $0.08 | – |
| FY2012 | Dec 31, 2012 | -$0.07 | – |
| FY2011 | Dec 31, 2011 | -$2.16 | – |
| FY2010 | Dec 31, 2010 | -$0.09 | -325.0% |
| FY2009 | Dec 31, 2009 | $0.04 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $0.15 | +36.4% |
| Q2 FY2026 | Jun 30, 2026 | $0.15 | +25.0% |
| Q1 FY2026 | Mar 31, 2026 | $0.05 | – |
| Q4 FY2025 | Dec 31, 2025 | $0.10 | +150.0% |
| Q3 FY2025 | Sep 30, 2025 | $0.11 | +37.5% |
| Q2 FY2025 | Jun 30, 2025 | $0.12 | +300.0% |
| Q1 FY2025 | Mar 31, 2025 | -$0.01 | – |
| Q4 FY2024 | Dec 31, 2024 | $0.04 | – |
| Q3 FY2024 | Sep 30, 2024 | $0.08 | +166.7% |
| Q2 FY2024 | Jun 30, 2024 | $0.03 | +50.0% |
| Q1 FY2024 | Mar 31, 2024 | -$0.05 | – |
| Q4 FY2023 | Dec 31, 2023 | $0.00 | – |
| Q3 FY2023 | Sep 30, 2023 | $0.03 | +50.0% |
| Q2 FY2023 | Jun 30, 2023 | $0.02 | – |
| Q1 FY2023 | Mar 31, 2023 | -$0.02 | – |
| Q4 FY2022 | Dec 31, 2022 | $0.00 | -100.0% |
| Q3 FY2022 | Sep 30, 2022 | $0.02 | – |
| Q2 FY2022 | Jun 30, 2022 | -$0.01 | -125.0% |
| Q1 FY2022 | Mar 31, 2022 | -$0.02 | -166.7% |
| Q4 FY2021 | Dec 31, 2021 | $0.02 | -95.9% |
| Q3 FY2021 | Sep 30, 2021 | -$0.02 | -114.3% |
| Q2 FY2021 | Jun 30, 2021 | $0.04 | -78.9% |
| Q1 FY2021 | Mar 31, 2021 | $0.03 | – |
| Q4 FY2020 | Dec 31, 2020 | $0.49 | +1125.0% |
| Q3 FY2020 | Sep 30, 2020 | $0.14 | +180.0% |
| Q2 FY2020 | Jun 30, 2020 | $0.19 | +850.0% |
| Q1 FY2020 | Mar 31, 2020 | -$0.02 | – |
| Q4 FY2019 | Dec 31, 2019 | $0.04 | – |
| Q3 FY2019 | Sep 30, 2019 | $0.05 | – |
| Q2 FY2019 | Jun 30, 2019 | $0.02 | – |
| Q1 FY2019 | Mar 31, 2019 | -$0.05 | -600.0% |
| Q4 FY2018 | Dec 31, 2018 | -$0.01 | – |
| Q3 FY2018 | Sep 30, 2018 | -$0.03 | – |
| Q2 FY2018 | Jun 30, 2018 | -$0.02 | – |
| Q1 FY2018 | Mar 31, 2018 | $0.01 | – |
| Q4 FY2017 | Dec 31, 2017 | -$0.79 | – |
| Q3 FY2017 | Sep 30, 2017 | -$0.01 | – |
| Q2 FY2017 | Jun 30, 2017 | -$0.05 | – |
| Q1 FY2017 | Mar 31, 2017 | -$0.07 | – |
| Q4 FY2016 | Dec 31, 2016 | -$0.02 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?